- BNF:
- GI system
- Status:
- Grey
- Decision Date:
- February 2023
Comments
Only after formulary choice Acidex advance is thought to be inappropriate due intolerance or inadequate symptom control. Grey Drug Classifications
- 5: Less cost-effective than current standard therapy
search again
